Ha-Jong Lee

Ha-Jong Lee is the Director of the New Drug Development Division at Dx & Vx, where they develop submission strategies and manage regulatory timelines for FDA, EMA, MFDS, and NMPA projects. Previously, they held various roles including Director at Nexturn Bio, Senior Manager at SillaJen, and Project & Country Manager at Celltrion, accumulating extensive experience in regulatory affairs, project management, and communication with stakeholders. Ha-Jong's work has resulted in numerous successful submissions and approvals across multiple international regulatory agencies. They hold a Bachelor's degree in Public Health from Northern Illinois University.